×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KYTX – kyverna therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KYTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/23
08:12 am
kytx
Kyverna Therapeutics (KYTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Medium
Report
Kyverna Therapeutics (KYTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
4/22
03:38 pm
kytx
Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis [Seeking Alpha]
Low
Report
Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis [Seeking Alpha]
4/21
06:45 pm
kytx
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Low
Report
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
4/21
07:37 am
kytx
Kyverna Therapeutics Positive Phase 2 Readout: Deep Responses, But Very Small Sample [Seeking Alpha]
High
Report
Kyverna Therapeutics Positive Phase 2 Readout: Deep Responses, But Very Small Sample [Seeking Alpha]
4/20
08:00 am
kytx
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
High
Report
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
4/9
08:00 am
kytx
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Medium
Report
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
3/26
04:02 pm
kytx
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
3/21
01:31 am
kytx
Kyverna Therapeutics (KYTX) was downgraded by Wall Street Zen from "h
Low
Report
Kyverna Therapeutics (KYTX) was downgraded by Wall Street Zen from "h
Date
Time
Symbol
Company Name
Action
%Chg
3/26/2026
04:02 pm
KYTX
kyverna therapeutics, inc.
IN-LINE
Report
-2.9%
kyverna therapeutics, inc.
11/12/2025
04:05 pm
KYTX
kyverna therapeutics, inc.
BEAT
Report
-4.7%
kyverna therapeutics, inc.
8/12/2025
04:02 pm
KYTX
kyverna therapeutics, inc.
BEAT
Report
14.9%
kyverna therapeutics, inc.
5/13/2025
04:02 pm
KYTX
kyverna therapeutics, inc.
BEAT
Report
-7.3%
kyverna therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/22
07:00 am
kytx
Form 8-K Kyverna Therapeutics, For: Apr 22
Medium
Report
Form 8-K Kyverna Therapeutics, For: Apr 22
4/22
06:01 am
kytx
Form 8-K Kyverna Therapeutics, For: Apr 21
High
Report
Form 8-K Kyverna Therapeutics, For: Apr 21
4/20
08:00 am
kytx
Form 8-K Kyverna Therapeutics, For: Apr 20
High
Report
Form 8-K Kyverna Therapeutics, For: Apr 20
4/17
04:37 pm
kytx
Form 144 Kyverna Therapeutics, Filed by: Walker Karen Marie
High
Report
Form 144 Kyverna Therapeutics, Filed by: Walker Karen Marie
4/14
04:39 pm
kytx
Form 144 Kyverna Therapeutics, Filed by: Walker Karen Marie
Low
Report
Form 144 Kyverna Therapeutics, Filed by: Walker Karen Marie
4/13
04:18 pm
kytx
Form ARS Kyverna Therapeutics, For: Dec 31
Low
Report
Form ARS Kyverna Therapeutics, For: Dec 31
4/13
04:10 pm
kytx
Form DEFA14A Kyverna Therapeutics,
Low
Report
Form DEFA14A Kyverna Therapeutics,
4/13
04:02 pm
kytx
Form DEF 14A Kyverna Therapeutics, For: May 27
Low
Report
Form DEF 14A Kyverna Therapeutics, For: May 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: